Symptomzentrierte Ansicht

Zahnverlust

Substanzen, die Zahnverlust disproportional melden — sortiert nach ROR.

Schmerzen Medikament unwirksam Off-Label-Anwendung Müdigkeit Atemnot Akute Nierenschädigung

20 von 20 angezeigt

Substanz ↓	ROR [95% CI]	Meldungen	Kategorie	Fachinformation
tenofovir disoproxil fumarate —	310.6 [301.8–319.6]	9.822	algemeen	neu
tenofovir alafenamide —	296.5 [287.5–305.8]	6.892	algemeen	neu
rilpivirine hydrochloride —	268.3 [256.0–281.1]	2.396	algemeen	neu
rilpivirine —	123.6 [118.3–129.3]	2.402	algemeen	neu
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate —	464.8 [440.2–490.7]	1.992	algemeen	neu
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide —	309.1 [285.5–334.7]	814	algemeen	neu
emtricitabine and tenofovir disoproxil fumarate —	382.2 [371.2–393.6]	8.779	algemeen	neu
emtricitabine and tenofovir alafenamide —	320.1 [310.0–330.4]	6.383	algemeen	neu
emtricitabine —	299.4 [291.0–308.0]	10.205	algemeen	neu
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate —	429.8 [409.4–451.3]	2.465	algemeen	neu
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide —	327.3 [311.6–343.8]	2.256	algemeen	neu
dolutegravir sodium and rilpivirine hydrochloride —	15.2 [10.3–22.4]	26	algemeen	neu
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide —	266.2 [242.2–292.5]	556	algemeen	neu
darunavir ethanolate and cobicistat —	28.2 [21.1–37.5]	48	algemeen	neu
darunavir —	37.8 [34.9–40.8]	672	algemeen	neu
cobicistat —	313.5 [302.1–325.5]	4.160	algemeen	neu
buprenorphine hydrochloride and naloxone hydrochloride —	14.8 [10.5–20.9]	33	algemeen	neu
buprenorphine and naloxone —	20.7 [13.8–31.0]	24	algemeen	neu
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate —	284.0 [272.8–295.7]	3.396	algemeen	neu
abacavir sulfate, dolutegravir sodium, lamivudine —	14.0 [11.3–17.3]	87	algemeen	neu

ROR = Reporting Odds Ratio gegenüber dem gesamten FAERS-Korpus. Ein Signal ist keine Ursache. Quelle: openFDA (FAERS).